Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Amant

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Carcinogenesis|October 4, 2011
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer StudyCatherine S Healey, Shahana Ahmed, , et al.
British Journal of Cancer|August 10, 2016
L1CAM expression in endometrial carcinomas: an ENITEC collaboration studyLouis Jm van der Putten, Nicole Cm Visser, Koen van de Vijver, et al.
Molecular Cancer|September 29, 2014
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancerLorena Alonso-Alconada, Laura Muinelo-Romay, Kadri Madissoo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2025
ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessmentMarike S Lombaers, Casper Reijnen, Ally Sprik, et al.
BMJ Open|November 16, 2017
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort studyGwen Mhe Dackus, Natalie D Ter Hoeve, Mark Opdam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 12, 2018
Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration StudyLouis J M van der Putten, Nicole C M Visser, Koen van de Vijver, et al.
British Journal of Cancer|April 24, 2019
Poor outcome in hypoxic endometrial carcinoma is related to vascular densityCasper Reijnen, Willem Jan van Weelden, Martijn S J P Arts, et al.
Plos Medicine|May 16, 2020
Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation studyCasper Reijnen, Evangelia Gogou, Nicole C M Visser, et al.
Breast (Edinburgh, Scotland)|September 23, 2025
Corrigendum to "Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial" [The Breast 83 (2025) 104547]Isabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
Breast (Edinburgh, Scotland)|July 31, 2025
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trialIsabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Carcinogenesis|October 4, 2011
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer StudyCatherine S Healey, Shahana Ahmed, , et al.
British Journal of Cancer|August 10, 2016
L1CAM expression in endometrial carcinomas: an ENITEC collaboration studyLouis Jm van der Putten, Nicole Cm Visser, Koen van de Vijver, et al.
Molecular Cancer|September 29, 2014
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancerLorena Alonso-Alconada, Laura Muinelo-Romay, Kadri Madissoo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2025
ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessmentMarike S Lombaers, Casper Reijnen, Ally Sprik, et al.
BMJ Open|November 16, 2017
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort studyGwen Mhe Dackus, Natalie D Ter Hoeve, Mark Opdam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 12, 2018
Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration StudyLouis J M van der Putten, Nicole C M Visser, Koen van de Vijver, et al.
British Journal of Cancer|April 24, 2019
Poor outcome in hypoxic endometrial carcinoma is related to vascular densityCasper Reijnen, Willem Jan van Weelden, Martijn S J P Arts, et al.
Plos Medicine|May 16, 2020
Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation studyCasper Reijnen, Evangelia Gogou, Nicole C M Visser, et al.
Breast (Edinburgh, Scotland)|September 23, 2025
Corrigendum to "Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial" [The Breast 83 (2025) 104547]Isabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
Breast (Edinburgh, Scotland)|July 31, 2025
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trialIsabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
Pageof 18